Copeland CS

Institute for Pharmaceutical Science, King's College London, London, UK.

7 papers · ORCID

ArticleMDMA

Population-Stratified Distributions of Post-Mortem Blood Drug Concentrations: An Epidemiological Framework for Contextual Interpretation.

Algahtani T, Rock KL, Rice-Davies K +4

Europe PMC2026
ArticleMDMA

The impact of antidepressant use on MDMA fatalities: A matched case-control study using a post-mortem database.

Rock KL, Rees P, Morgan D +1

Europe PMC2026
ArticleDMT

Fatalities following DMT use: two case reports and a review of the literature.

Pullen J, Moore R, Wood R +3

Europe PMC2025
ArticleKetamine

Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024: An update report to inform the reclassification debate.

Pullen J, Corkery JM, McKnight R +1

Europe PMC2026
ArticlePsilocybin

Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).

Kopra EI, Penttinen J, Rucker JJ +1

Europe PMC2025
ArticleLSD

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD).

Kopra EI, Ferris JA, Rucker JJ +4

Europe PMC2022
ArticleKetamine

Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.

Corkery JM, Hung WC, Claridge H +3

Europe PMC2021